Ouro Fino Saúde Animal Participações S.A Cash Flow Conversion Efficiency
Ouro Fino Saúde Animal Participações S.A cash flow conversion efficiency. Based on the latest financial reports, Ouro Fino Saúde Animal Participações S.A (OFSA3) has a cash flow conversion efficiency ratio of 0.166x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$135.27 Million ≈ $26.54 Million USD) by net assets (R$816.49 Million ≈ $160.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OFSA3 company net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Ouro Fino Saúde Animal Participações S.A (2011–2025)
Cash flow conversion efficiency of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025. This chart illustrates how Ouro Fino Saúde Animal Participações S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View OFSA3 share price today for real-time trading data and today's change.
Ouro Fino Saúde Animal Participações S.A Cash Flow Conversion Ratio Explained
Ouro Fino Saúde Animal Participações S.A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ouro Fino Saúde Animal Participações S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ouro Fino Saúde Animal Participações S.A ranked by their cash flow conversion efficiency. Review OFSA3 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vysarn Ltd
AU:VYS
|
0.088x |
|
Air Asia Co Ltd
TW:2630
|
-0.006x |
|
Electrovaya Inc.
NASDAQ:ELVA
|
-0.174x |
|
GENERALFINANCE SPA
F:VG30
|
-0.212x |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
N/A |
|
RichWave Technology Corp
TW:4968
|
-0.010x |
|
Tyro Payments Ltd
AU:TYR
|
0.646x |
|
Nuveen Core Plus Impact Fund
NYSE:NPCT
|
N/A |
Annual Cash Flow Conversion Efficiency for Ouro Fino Saúde Animal Participações S.A (2011–2025)
The table below shows the annual cash flow conversion efficiency of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025. Also see OFSA3 total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | R$796.86 Million ≈ $156.36 Million |
R$99.91 Million ≈ $19.60 Million |
0.125x | +28.27% |
| 2024-12-31 | R$756.40 Million ≈ $148.42 Million |
R$73.94 Million ≈ $14.51 Million |
0.098x | -64.59% |
| 2023-12-31 | R$689.39 Million ≈ $135.27 Million |
R$190.30 Million ≈ $37.34 Million |
0.276x | +126.76% |
| 2022-12-31 | R$735.95 Million ≈ $144.41 Million |
R$89.59 Million ≈ $17.58 Million |
0.122x | +67.93% |
| 2021-12-31 | R$641.45 Million ≈ $125.86 Million |
R$46.50 Million ≈ $9.12 Million |
0.072x | -63.68% |
| 2020-12-31 | R$560.78 Million ≈ $110.03 Million |
R$111.94 Million ≈ $21.96 Million |
0.200x | +74.32% |
| 2019-12-31 | R$492.45 Million ≈ $96.63 Million |
R$56.39 Million ≈ $11.06 Million |
0.115x | +21.96% |
| 2018-12-31 | R$455.94 Million ≈ $89.46 Million |
R$42.81 Million ≈ $8.40 Million |
0.094x | -61.70% |
| 2017-12-31 | R$405.88 Million ≈ $79.64 Million |
R$99.50 Million ≈ $19.52 Million |
0.245x | +118.41% |
| 2016-12-31 | R$376.33 Million ≈ $73.84 Million |
R$42.24 Million ≈ $8.29 Million |
0.112x | +175.25% |
| 2015-12-31 | R$380.31 Million ≈ $74.62 Million |
R$15.51 Million ≈ $3.04 Million |
0.041x | +1478.41% |
| 2014-12-31 | R$330.16 Million ≈ $64.78 Million |
R$853.00K ≈ $167.37K |
0.003x | -98.38% |
| 2013-12-31 | R$209.42 Million ≈ $41.09 Million |
R$33.45 Million ≈ $6.56 Million |
0.160x | -6.07% |
| 2012-12-31 | R$194.84 Million ≈ $38.23 Million |
R$33.13 Million ≈ $6.50 Million |
0.170x | +114.04% |
| 2011-12-31 | R$177.44 Million ≈ $34.82 Million |
R$14.10 Million ≈ $2.77 Million |
0.079x | -- |
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more